bupropion

(redirected from Wellbutrin sr)
Also found in: Dictionary.

bupropion

 [bu-pro´pe-on]
a compound structurally similar to amphetamine, used in the form of the hydrochloride salt as an antidepressant and as an aid in smoking cessation to reduce the symptoms of nicotine withdrawal; administered orally.

bupropion

/bu·pro·pi·on/ (bu-pro´pe-on) a monocyclic compound structurally similar to amphetamine, used as the hydrochloride salt as an antidepressant and as an aid in smoking cessation.

bupropion

(byo͞o-prō′pē-ŏn′)
n.
A drug, C13H18ClNO, used in its hydrochloride form for the treatment of depression and as an aid in smoking cessation. It is a weak inhibitor of norepinephrine and dopamine reuptake in the central nervous system.

buPROPion

[boo͡prō′pē·on]
a heterocyclic mood-elevating drug used to treat some types of depression (trademark: Wellbutrin) and also to promote smoking cessation (trademark: Zyban).

bupropion

Zyban® Psychiatry An antidepressant Side effects Dry mouth, insomnia Contraindications Seizures, bulimia

bupropion

A drug used in the treatment of tobacco, drug and alcohol dependency. Bupropion reacts adversely with a wide range of other drugs and may induce seizures in sensitive persons. When used, a strict regime is necessary. A brand name is Zyban.

Bupropion

An antidepressant medication given to smokers for nicotine withdrawal symptoms. It is sold under the trade name Zyban.

bupropion (byōō´prō´pēon),

n brand names: Wellbutrin, Zyban;
drug class: antidepressant;
action: weak uptake inhibitor of dopamine, serotonin, norepinephrine; mechanism unknown;
uses: treatment of depression and anxiety disorders; tobacco cessation.
References in periodicals archive ?
Annual sales of Wellbutrin SR 100mg and 200mg and the generic equivalent in that strength in the United States was USD115 million for the 12 months ending March 2010 according to IMS Health data.
What it is: Bupropion is an antidepressant sold as Zyban or Wellbutrin SR.
GlaxoSmithKline dropped 16p to 1250p on fears that its antidepressant Wellbutrin SR could face US competition.
Should not be given to patients already taking Welibutrin or Wellbutrin SR, as these also contain bupropion.
The first, Wellbutrin SR, is a buproprion hydrochloride extended-release tablet marketed by Glaxo Wellcome, Inc.
The company said the US Food & Drug Administration (USFDA) approved Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg in the US is the therapeutic equivalent generic version of Wellbutrin SR (bupropion HCl) Sustained-Release Tablets.
Other non-neurotropic drugs: isotretinoin (Accutane--used to treat acne), cyclosporine (Grengraf, Neoral, Sandimmune, Sangcya--used to treat organ rejection, rheumatoid arthritis, psoriasis), mefloquine (Larium--used to prevent and treat malaria), trihexyphenidyl (Artane--used to treat tremors and symptoms of Parkinson's disease), hepatitis B vaccine, and the atypical antidepressant bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL, Zyban, Budeprion--used to treat depression, seasonal affective disorder, and to promote smoking cessation).
Bupropion HCl SR tablets, the genetic equivalent of Wellbutrin SR (GlaxoSmithKline PLC) are now available from Actavis in the following strengths: 100, 150 and 200 mg.
ID=9266) and some give advice on extracting bupropion from Wellbutrin SR tablets for the purpose of insufflation (http://bupropion.
The study lasted 8 weeks and was partially funded by Glaxo-Wellcome, the maker of sustained-release bupropion, which is marketed as Wellbutrin SR for depression and as Zyban for smoking cessation.
He managed strategic planning and tactical execution for the introduction of Wellbutrin SR and launching the opioid analgesic remifentanil (Ultiva).
M2 EQUITYBITES-22 July 2010-Caraco Pharmaceutical Laboratories Ltd unveils generic Wellbutrin SR extended release tablets in market(C)2010 M2 COMMUNICATIONS http://www.